Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52 GBX | 0.00% | 0.00% | +0.97% |
Apr. 23 | Cambridge Cognition partly-owned spin-off gets GBP1.5 million funding | AN |
Apr. 23 | Cambridge Cognition's Spin-Out Company Closes Fundraise for Schizophrenia Drug | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.97% | 20.14M | - | ||
-20.09% | 26.53B | C | ||
+1.38% | 9.32B | - | ||
-6.43% | 4.6B | C | ||
-25.68% | 729M | - | ||
-1.92% | 479M | - | - | |
-9.71% | 448M | - | ||
-9.63% | 273M | - | - | |
-28.88% | 210M | - | - | |
-42.63% | 189M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- COG Stock
- Ratings Cambridge Cognition Holdings Plc